期刊
SEMINARS IN CANCER BIOLOGY
卷 11, 期 5, 页码 339-352出版社
ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
DOI: 10.1006/scbi.2001.0389
关键词
antiestrogens; breast cancer; co-regulatory factors; estrogen receptor
类别
Breast cancer, the most common malignancy in women, was already known to be associated with the steroid hormone estrogen more than a century ago. The discovery of the estrogen receptor (ER) provided us not only with a powerful predictive and prognostic marker, but also an efficient target for the treatment of hormone-dependent breast cancer with antiestrogens. In this paper we will sketch the important role of ER in the development, progression, and treatment of the disease, which is complicated by the receptor's interaction with coregulatory proteins, its cross-talk with other signal transduction pathways, and its involvement in the development of antiestrogen resistance.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据